Участник:NewOriginalSchwann/Sandbox2

Building a brighter future.

Overview

This is a main page for a playable corporation. Information here is important should you wish to play a contractor relating to this.

Zeng-Hu Pharmaceuticals is a trans-stellar medical research and pharmaceutical conglomerate with origins on 21st century Earth. They are responsible for the invention of modern cloning techniques, and have a hand in almost every form of medicine throughout the Orion Spur. Zeng-Hu has a unique internal structure referred to as the keiretsu by its employees: while a megacorporation officially it is made up of dozens of specialized medical corporations which build off of their mutual success, creating a structure most similar to a cartel.

Influence

As the foremost medical service in the galaxy, overshadowing the former monopoly NanoTrasen once had over the specialty, Zeng-Hu's influence is immense. Their responsibility extends to the health and well-being of almost all citizens of the major galactic powers, with its constituent corporations delving into the pedantics of healthcare across the Orion Spur.

General

Current CEO: Liqin Hsiao-Li

One of the smartest living humans in the Orion Spur, Doctor Hsiao-Li secured her position as the head of Zeng-Hu Pharmaceuticals through ability rather than family relations, and has seen Zeng-Hu secure significant shares of the human and skrellian biotech markets under her watchful eye. Hsiao-Li has a reputation as an extremely strict woman, even amongst Zeng-Hu Pharmaceutical board members, that does not tolerate failure. This has worked wonders for the reputation of the company’s workers, as one screw-up is enough to get them fired, but has made Zeng-Hu Pharmaceuticals a much more stressful company to work for than its main competitor of NanoTrasen. However, should an employee show success, Hsiao-Li rewards it.

Official Title(s): Zeng-Hu Pharmaceuticals, Zeng-Hu Medical Corporation, Zeng-Hu Corporate Conglomerate

Motto: Building a brighter future.

Headquarters: Isis, Oran, Epsilon Eridani

Official Languages: Tradeband, Tau Ceti Basic, Sol Common, Terran Mandarin

Primary Color Scheme: Purple, white and pink

Executives and Branches

Executives

Zeng-Hu Pharmaceuticals is run by the Board of Directors, lead by Chairman and President Hou Hsiao-Li and appointed by the constituent corporations making up Zeng-Hu's web of businesses. The Board oversees the general function of the entire keiretsu, with constituent boards managing their own corporations more directly.

President: Liqin Hsiao-Li, 108, Human

Vice President: Rochelle Mohi, 74, Human

Chief Medical Officer: Cisi Cho, 82, Human

Chief Research Officer: Ormish Jrolk, 364, Skrell

Chief Information Officer: Mari Lesokho, 57, Human

Chief Communications Officer: Victor Martinez-Park, 38, Human

Chief Financial Officer: Kianna Zhang, 44, Human

Chief Operations Officer: Alexander Miyawaki, 51, Human

Chief Security Officer: Richard Moors, 39, Human

Branches

Though their headquarters are in Epsilon Eridani, Zeng-Hu Pharmaceuticals can be found throughout many areas in human space. Here are the locations of their primary and largest branches.

Isis, Oran, Epsilon Eridani: The headquarters of Zeng-Hu Pharmaceuticals can be found on Oran. The skyscraper is notable for being decorated in an interesting mix of traditional Terran Chinese and corporate Eridanian styles. The Board of Directors are housed in the upper floors, with the highest levels being for corporate activity.

Shanghai, China, Earth, Sol: The Shanghai branch oversees most of Zeng-Hu’s activity in the Sol Alliance. With nearly twice the amount of workers as the second-most staffed headquarters, the Shanghai branch is an incredibly lively, bustling place.

Mendell City, Biesel, Tau Ceti: The Mendell City branch can be found in Xinghua Prefecture, standing tall among the surrounding complexes. Security is incredibly tight in Mendell City, though officials refuse to directly answer why.

Constituent Corporations

Bishop Cybernetics

"Without compromise."

General

Bishop Cybernetics is a relatively young subsidiary of Zeng-Hu Pharmaceuticals, founded on Biesel in April of 2418. They specialize in innovations in biomechanical engineering with a focus on prosthetics and mechanical organs.

Influence

Epsilon Eridani: Four major equipment manufacturing facilities on Oran.

Tau Ceti: Headquarters in Mendell City, Biesel; three research and development facilities on Biesel.

Executives

Chief Executive Officer: Grant Bishop, 62, Human

Chief Engineering Officer: Maali Islamova, 57, Human

Chief Research Officer: Maxim Pangan-Roces, 58, Human

Chief Information Officer: Kareena Mayadev-Calli, 49, Human

Chief Design Officer: Youa Mo Xvooj-Hayashi, 45, Human

History

Bishop Cybernetics was founded on Biesel by Grant Bishop and Owen Harrison. Both had dropped out of study at the Biesel Institute of Robotics to focus on business. Even though prosthetics wasn't a new field by any means, and it was mostly dominated by giants like Zeng-Hu and Hephaestus, Bishop felt there was room for innovation.

Bishop and Harrison both worked out of Bishop's personal pod bay for their first year, working to improve on the existing design for a mechanical prosthetic hand. They unveiled this new design at the annual Mendell City Innovation Conference and caught the attention of several investors with their flashy, sleek design with an integrated holo-watch, communications center, and patented user interface with a haptic feedback enabled holographic display. Most notable about this first design was the fact its power draw was no greater than other designs already out there, despite running several different accessory modules.

After a wildly successful campaign spanning over ten years showcasing every iteration of their new prosthetics at every opportunity, Bishop Cybernetics opened their first major manufacturing facility on Isis in 2430. This drastically reduced the costs associated with production and allowed Bishop Cybernetics to become even more profitable. The high-energy Grant Bishop still attends conferences and events, giving speeches and demonstrations, and often makes a point to show off his own prosthetic arms and eyes, which he has linked to his own home devices including his thermostat, doors, electrochromic windows and microwave. In 2456, Bishop suffered from heart failure, and underwent an operation to have a Bishop Cybernetics mechanical heart installed. He has since claimed to be "synthetic at heart", coming back from the operation to announce a new division of Bishop Cybernetics focusing on synthetic intelligence research.

Bishop Cybernetics' focus on power efficiency, luxury, and innovation meant its niche market was composed mostly of technological enthusiasts and a number of transhumanist fanatics. This is, of course, not without controversy, especially among more traditionally-minded consumers skeptical of the radical ideas usually pushed by Bishop Cybernetics. The heavy regulation of prosthetic devices often means the most attention-grabbing products are meant for headlines only, kept behind red tape to never leave the showroom. Uncomfortable with Bishop's direction, Owen Harrison officially resigned from the company in December 2458.

The continued growth of Bishop Cybernetics has proven without a doubt that there is a small, but lucrative market for these big ideas and the controversy often stirred with Bishop's ideals has ensured they have a place in headlines on a yearly basis.

During the last conference held during a conference on Biesel in August 2459, Bishop shared the stage with a state-of-the-art IPC designated "Axiom". This IPC's frame was entirely by Bishop, with a glass-encased hologram display for a face and a claimed internal battery life lasting for up to three weeks on standby. It isn't known when, or even if, this model will ever be approved for production.

Jeonshi Biotech Incorporated

"Foremost among flowers."

General

Jeonshi Biotech is a major member of the Zeng-Hu Pharmaceuticals keiretsu, founded on Earth in October of 2289. They specialize in the creation and design of mechanical and biological augments for both humans and common positronic frames such as the famous Zeng-Hu Mobility Frame.

Influence

Sol: Headquarters in Busan, Korea, Earth; five research and development facilities across Earth.

Tau Ceti: Research and development facility in Mendell City, Biesel.

Epsilon Eridani: Two major manufacturing facilities on Oran.

Executives

Chief Executive Officer: Yunji Kyong, 76, Human

Chief Research Officer: Ju Li, 18, Postronic Shell Frame

Chief Data Officer: Songho Sam, 57, Human

Chief Communications Officer: Biyu Tian-Kim, 46, Human

Chief Commercial Officer: Kaya Kinjo-Song, 51, Human

History

Founded by a collection of cutting-edge Chinese and Japanese robotics companies in 2289, Jeonshi Biotech quickly established itself as a leader in the biotech industry on Earth and joined the Zeng-Hu conglomerate in 2302. The corporation has maintained its cutting edge in bio-technology ever since, despite rumors regarding unethical experimentation in order to create more effective augmentations. Most attribute these rumors to Zavodskoi Interstellar, Jeonshi Biotech's main competitor in the field of military-grade augmentations.

Jeonshi Biotech was, despite its Solarian roots, one of the first major corporations to look upon modern positronics as more than cheap labor. Synthetic employees — and property — of Jeonshi are treated much better than most others, to the point where they are capable of rising to the board of directors if they are competent and lucky enough. CRO Ju Li (previously Zeng-Hu Research Android Ju-010892), a shell, is held up by the corporation as an example of how high a positronic can rise in Jeonshi Biotech.

Yomi Genetics Innovation and Research

"The spider lily blooms."

General

Yomi Generics I&R is a constituent corporation of Zeng-Hu Pharmaceuticals, founded on Earth in 2306. They are known for their cutting-edge genetics research, and their close relationship with the Jargon Federation.

Influence

Sol: Headquarters in Tokyo, Japan, Earth; nine major farming facilities across Earth; three major processing plants on Earth.

Tau Ceti: One major farming facility and processing plant on Biesel.

Executives

President: Miho Kumagai-Wan, 85, Human

Deputy President: Xinyi Huang, 71, Human

General Manager: Kotaro Tamaki, 59, Human

Chief Research Officer: Jong-Su Chun-Gao, 64, Human

Chief Development Officer: Mineko Makino-Min, 55, Human

History

Originally established in 2306 by several leading geneticists, Yomi Genetics is one of the later members to join Zeng-Hu's massive conglomerate and join the keiretsu in 2311 in order to acquire more funding for its mostly-theoretical research into genetics. The corporation started off as a small and mostly research-oriented member of the Zeng-Hu conglomerate with very few practical products until first contact with the skrell was established. The resulting genetics boom caused a golden age for corporation, and has seen it on the cutting edge of genetics research ever since.

As a result of their place on the forefront of genetics research Yomi maintains the largest gene bank in the Orion Spur, for both research and business purposes. Yomi is additionally responsible for much of the research that led to the invention and creation of modern cloning techniques. However, due to the prohibitively expensive cost of cloning, the corporation does not consider it a priority for research - instead it has opted to focus upon the practicality of vat-grown limbs as a commercial product. How this development will impact the future of the medical field remains to be seen.

Drive and Agenda

Zeng-Hu Pharmaceuticals, and the majority of its minor subsidiaries, are professional science at its core. The public-facing sections of the megacorporation operate one of the larger public relations departments in the galaxy, a necessity for something as controversial as the primary healthcare provider. This reflects on employees as their workforce is encouraged to be plotting and outright secretive. In addition, the openly declared pursuit of Zeng-Hu has been the perfection of the sentient form and rapidly progressing what could be construed as the "expected evolution" of Humanity. The details of the future of this expectation are unfortunately classified, and guesses as to what the corporation plans are varied — from grounded to completely ridiculous conspiracies.

Commercial contracting with Zeng-Hu is a cut-throat, careless business where decisions from completely untraceable elements within the corporation drift down to the lower ranks, usually deciding the course of lives. Workers take pride in their own capability to dodge the unknowable forces above, inadvertently, and the ideology has ended up fostering one of two things; either fear for one’s superiors or a dangerous lack of care. The latter in this environment rarely ends well.

Zeng-Hu Pharmaceuticals rarely works alongside Zavodskoi contractors, and intentionally so. The two corporations frequently butt heads after Zeng-Hu Pharmaceuticals left Zavodskoi genetics research in the dust, with the relation between the two sours at best. This echoes down to the lowest ranks, as even the common worker can find themselves cheered on to beat the opposition. This isn’t an excuse to get fired by trashing your coworker.

History

Zeng-Hu Pharmaceuticals was born from the merging of nearly a dozen companies on Earth in the year 2032, creating a complete stranglehold over the medical field while avoiding traditional anti-trust laws. The keiretsu pioneered the way in the field of cryonics and cryogenics, manufacturing the first truly viable "cryopod" designed to safely house a human being during long-distance space travel. This proved instrumental during the colonization efforts of Mars and Luna. However, the success was relatively short-lived, as the economic hardships of the mid-22nd century hit the conglomerate hard. While never completely disappearing, it was overshadowed by the rise of other corporations edging in on the field of biotechnology and pharmaceuticals. Zeng-Hu stayed in the background for years, though their continual innovations and unique internal structure allowed them to stay somewhat competitive.

It wasn't until the year 2332, when the Skrell were first encountered, that it was well and truly thrust back into the limelight. As with many other companies jockeying for positions from which they could benefit from the advanced technology of the Skrell, Zeng-Hu sent representatives to try and convince Skrellian scientists to establish joint cooperative research teams with their own scientists. However, unlike with the other corporations, whom most of the scientific community of the Skrell perceived as simply greedy, they were truly impressed by the vision and drive shown by the CEO Vanas Peng and his board of directors. After three years of cooperative research, the first viable example of cloning technology was created.

Zeng-Hu was quick to patent the techniques and equipment, and continued to advance in the newly created field of the cloning of sentient organisms. Techniques were developed that allowed clones to have direct copies of a subject's memories and personalities implanted in their psyche. While cloning technology was highly controversial when first introduced, it has since become an accepted and even promoted part of Human and Skrellian society.

Zeng-Hu Pharmaceuticals is now among the most powerful trans-stellar corporations present in the galaxy in the modern day. Today, Zeng-Hu Pharmaceuticals works closely with Nanotrasen Corporation through a series of mutually beneficial economic and research agreements. Zeng-Hu provides the newest advancements in cloning technology to Nanotrasen for use on their facilities, and Nanotrasen in turn loans their best researchers to assist Zeng-Hu with further advancement and development.